Opioid Use Disorder

The AHA supports a number of proposed policy changes that ensure access to care, support public health efforts, improve quality and promote regulatory relief. Specifically, we strongly support CMS’s proposed reversal of its previously finalized policies for evaluation and management payments.
AHA's feedback on the Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation’s request for information on ensuring patient access and effective drug enforcement regarding controlled substances.
On Oct. 24, 2018, President Trump signed into law the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (P.L. 115-271).
We were pleased to see the House of Representatives this week move forward dozens of bills designed to address aspects of the opioid epidemic that costs more than 100 American lives each day and continues to ravage communities across the nation.
Letter to the Senate Finance Committee leadership supporting the Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018.
The House Energy and Commerce Committee yesterday approved 32 bills to address the opioid crisis, including 12 AHA-supported bills.
AHA comments to the House Subcommittee on Health Energy and Commerce on bills related to the opioid crisis.